Amgen Balance Sheet

AMGN / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)

Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.

At a glance

Total Assets

$90.6B

FY2025

Cash

$9.1B

Cash and equivalents

Total Debt

$54.6B

FY2025

Shareholder Equity

$8.7B

FY2025

New to balance sheets? Read the quick guide.

Amgen had $90.6B in total assets and $8.7B in shareholders' equity as of FY2025. Total debt was $54.6B against $9.1B in cash, resulting in $45.5B net debt.

Based on SEC 10-K filings.

Key Data Points

Altman Z-Score NaN (distress zone, below 1.23 threshold)
High leverage: Debt-to-equity ratio of 6.31
Profit margin: 21.0% of revenue retained as profit

Data sourced from SEC EDGAR filings. Not investment advice.

Item	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Cash & Equivalents	$9.1B	$12.0B	$10.9B	$7.6B	$8.0B	$6.3B	$6.0B	$6.9B	$3.8B	$3.2B	$4.1B	$3.7B	$3.8B	$3.3B	$6.9B
Accounts Receivable	$9.6B	$6.8B	$7.3B	$5.6B	$4.9B	$4.5B	$4.1B	$3.6B	$3.2B	$3.2B	$3.0B	$2.5B	$2.7B	$2.5B	$2.9B
Inventory	$6.2B	$7.0B	$9.5B	$4.9B	$4.1B	$3.9B	$3.6B	$2.9B	$2.8B	$2.7B	$2.4B	$2.6B	$3.0B	$2.7B	$2.5B
Current Assets	$29.1B	$29.0B	$30.3B	$22.2B	$19.4B	$21.1B	$18.4B	$37.6B	$49.5B	$46.0B	$38.5B	$34.7B	$27.4B	$31.2B	$27.6B
PP&E (Net)	$7.9B	$6.5B	$5.9B	$5.4B	$5.2B	$4.9B	$4.9B	$5.0B	$5.0B	$5.0B	$4.9B	$5.2B	$5.3B	$5.3B	$5.4B
Goodwill	$18.7B	$18.6B	$18.6B	$15.5B	$14.9B	$14.7B	$14.7B	$14.7B	$14.8B	$14.8B	$14.8B	$14.8B	$15.0B	$12.7B	$11.8B
Total Assets	$90.6B	$91.8B	$97.2B	$65.1B	$61.2B	$62.9B	$59.7B	$66.4B	$80.0B	$77.6B	$71.4B	$69.0B	$66.1B	$54.3B	$48.9B
Current Liabilities	$25.5B	$23.1B	$18.4B	$15.7B	$12.2B	$11.7B	$12.8B	$13.5B	$9.0B	$11.2B	$8.7B	$7.0B	$7.9B	$8.2B	$5.8B
Total Debt	$54.6B	$60.1B	$64.6B	$38.9B	$33.3B	$33.0B	$29.9B	$33.9B	$35.3B	$34.6B	$31.4B	$30.7B	$32.1B	$26.5B	$21.4B
Shareholders' Equity	$8.7B	$5.9B	$6.2B	$3.7B	$6.7B	$9.4B	$9.7B	$12.5B	$25.2B	$29.9B	$28.1B	$25.8B	$22.1B	$19.1B	$19.0B

Other Financial Statements

Income Statement Cash Flow Statement All Financial Data

Scores & Analysis

Piotroski F-Score Altman Z-Score Financial Ratios

Amgen Profile All Financial Data

Item

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

Cash & Equivalents

$9.1B

$12.0B

$10.9B

$7.6B

$8.0B

$6.3B

$6.0B

$6.9B

$3.8B

$3.2B

$4.1B

$3.7B

$3.8B

$3.3B

$6.9B

Accounts Receivable

$9.6B

$6.8B

$7.3B

$5.6B

$4.9B

$4.5B

$4.1B

$3.6B

$3.2B

$3.0B

$2.5B

$2.7B

$2.5B

$2.9B

Inventory

$6.2B

$7.0B

$9.5B

$4.9B

$4.1B

$3.9B

$3.6B

$2.9B

$2.8B

$2.7B

$2.4B

$2.6B

$3.0B

$2.7B

$2.5B

Current Assets

$29.1B

$29.0B

$30.3B

$22.2B

$19.4B

$21.1B

$18.4B

$37.6B

$49.5B

$46.0B

$38.5B

$34.7B

$27.4B

$31.2B

$27.6B

PP&E (Net)

$7.9B

$6.5B

$5.9B

$5.4B

$5.2B

$4.9B

$5.0B

$4.9B

$5.2B

$5.3B

$5.4B

Goodwill

$18.7B

$18.6B

$15.5B

$14.9B

$14.7B

$14.8B

$15.0B

$12.7B

$11.8B

Total Assets

$90.6B

$91.8B

$97.2B

$65.1B

$61.2B

$62.9B

$59.7B

$66.4B

$80.0B

$77.6B

$71.4B

$69.0B

$66.1B

$54.3B

$48.9B

Current Liabilities

$25.5B

$23.1B

$18.4B

$15.7B

$12.2B

$11.7B

$12.8B

$13.5B

$9.0B

$11.2B

$8.7B

$7.0B

$7.9B

$8.2B

$5.8B

Total Debt

$54.6B

$60.1B

$64.6B

$38.9B

$33.3B

$33.0B

$29.9B

$33.9B

$35.3B

$34.6B

$31.4B

$30.7B

$32.1B

$26.5B

$21.4B

Shareholders' Equity

$8.7B

$5.9B

$6.2B

$3.7B

$6.7B

$9.4B

$9.7B

$12.5B

$25.2B

$29.9B

$28.1B

$25.8B

$22.1B

$19.1B

$19.0B